Chief Pharmacist

Statistics Required in Formulation Development

Chief Pharmacist

1. Formulation development is not trial and error. 2. The purpose of statistics in pharmaceutical R and D is not ...

A Bioequivalence Lesson Experience

Chief Pharmacist

As R&D leaders, we often approve programs that look flawless on paper. Same API. Same grade. Formulation physicochemical characteristics aligned. ...

Do Pharmacopeial Methods Need Forced Degradation Studies?

Chief Pharmacist

It’s a fairly common question. Usually built on assumptions like: So, the conclusion becomes: 𝘞𝘩𝘺 𝘋𝘖 𝘧𝘰𝘳𝘤𝘦𝘥 𝘥𝘦𝘨𝘳𝘢𝘥𝘢𝘵𝘪𝘰𝘯 𝘢𝘵 𝘢𝘭𝘭? ...

Does f2 Apply to Modified-Release Dissolution Profiles?

Chief Pharmacist

Short answer: Yes. But only if you meet the prerequisites Most of us learn f2 through immediate-release examples. That’s why ...

Root Cause Analysis in Pharmaceutical Industry

Chief Pharmacist

Root cause analysis (RCA) is a systematic process used in the pharmaceutical industry to identify the underlying factors that contribute ...

Bound Water vs Free Water

Chief Pharmacist

Understanding water states is essential in formulation, stability, and lyophilization. Here’s the simplest breakdown: Bound Water Free Water Why it ...

Computer System Assurance

Chief Pharmacist

Computer System Assurance (CSA) refers to the comprehensive and systematic approach taken by organizations to ensure the reliability, security, and ...

CSV Qualification Summary Report

Chief Pharmacist

A Computer System Validation (CSV) Qualification Summary Report is a comprehensive document that provides an overview of the validation process ...

Difference Between 21 CFR Part 11 and Annex 11

Chief Pharmacist

21 CFR Part 11 and Annex 11 are both regulatory guidelines that provide requirements for electronic records and electronic signatures ...

What is a Non-GxP System?

Chief Pharmacist

Non-GxP systems do not affect product quality, patient safety, or regulatory decisions. Validation effort here is minimal or not required. ...

Determining GxP Relevant Software

Chief Pharmacist

Determining whether a software system is GxP (Good Practice) relevant in the pharmaceutical industry involves assessing its impact on processes ...

Software Development Life Cycle in Pharmaceutical Industry

Chief Pharmacist

In the pharmaceutical industry, the software development life cycle (SDLC) consists of several phases that ensure the proper development, validation, ...